Leadership Change

Beyond the ad break: How TripleLift's focus on creative formats, global retail media partnerships, and AI is disrupting the programmatic advertising landscape.

Bristol Myers Squibb's Opdivo gets FDA priority review, backed by landmark data suggesting it could unseat a key competitor as the new gold standard.

After major setbacks, a surge of innovative drugs is set to transform the ALS market. We decode the science, the money, and what it means for patients.

Match Group bets big on the future of dating, spinning out an AI venture while a new CEO steers Hinge toward its projected $1 billion revenue goal.

As CEO De Lyle Bloomquist announces his retirement, Rayonier Advanced Materials seeks a new leader to steer its ambitious 'BioFuture' strategy amid market volatility.

Benchmark Electronics poaches a key executive from rival Flex, signaling an aggressive push for commercial growth and supply chain resilience under new leadership.

Kim Thinggaard's return as CEO of Enemærke & Petersen signals a strategic doubling-down on the trust-based partnership model he pioneered.

Cybersecurity leader Mimecast bets big on Singapore, tackling AI threats and data sovereignty to capture the booming Asia-Pacific market. Here’s why it matters.

With its new CRO from Asana and LinkedIn, HR tech unicorn Lattice is betting on a human-centric AI strategy to dominate the future of performance management.

IPC Systems' new NYC hub isn't just a lease. It's a strategic bet on physical proximity as the core of resilient, innovative financial technology.

Klaviyo appoints a veteran scaler as co-CEO in a bold move to let its founder focus solely on AI. Is this the new leadership model for tech dominance?

Angeion Group's appointment of a legal marketing veteran isn't just a new hire; it's a calculated move to challenge rivals and dominate its niche.

Why a top security leader's move from a tech giant to a specialized firm signals a major shift in the fight for digital resilience. A deep dive.

Dr. Timothy Lubenow's move from a top university to a community clinic highlights a trend that's making advanced medical care more accessible.

PERIOD. appoints Jennifer Herrera as its new ED. How will her background in national advocacy and grassroots organizing reshape the fight for menstrual equity?

GoldMining Inc. renews its flexible financing tool to tap the market. We analyze the strategy, the projects at stake, and the dilution dilemma for investors.

As consumer debt soars, a key advocacy group's new data-focused leadership could turn a powerful analytical lens on the role of healthcare and drug prices.

A nonprofit's anniversary reveals a powerful brand strategy: using data and free software to find families for 13,000+ children lost in the system.

With a new SVP of Growth, John Henry, RestorixHealth signals an aggressive push in the booming wound care market, navigating tech shifts and regulatory hurdles.

Amid a CEO change, Sherritt International faces a pivotal moment. Can a new leader steer its vital nickel and cobalt assets through volatile markets?